Wellington Partners

HepaRegeniX GmbH, founded in 2016 and based in Ulm, Germany, focuses on developing innovative drugs for acute and chronic liver diseases. The company's therapeutic approach is centered on a proprietary molecular target known as mitogen-activated protein kinase 4 (MKK4), identified as a crucial regulator of liver regeneration through research by Professor Lars Zender and his team at the University Hospital Tübingen. HepaRegeniX aims to create small-molecule inhibitors of MKK4 that can enhance the regenerative capacity of hepatocytes, even in severely diseased livers. This research has significant implications for treating various liver disorders, including nonalcoholic steatohepatitis.

Aignostics GmbH, founded in 2018 and based in Berlin, Germany, specializes in AI-powered diagnostics and pathology software solutions aimed at enhancing pharmaceutical research and clinical diagnostics. The company focuses on precision diagnostics in pathology, employing its patented technology to create explainable AI systems that address the limitations of traditional AI models. By generating precise heatmaps and image overlays, Aignostics' platform enables pathologists to quickly verify AI-generated diagnostic results. This capability is essential for ensuring accuracy in diagnoses, particularly for complex diseases such as cancer. The company's innovative approach supports the discovery and validation of biomarkers, facilitating improved diagnosis and treatment strategies in precision medicine.

Sphingotec GmbH is a biomarker company based in Brandenburg, Germany, founded in 2002. The company specializes in developing and marketing in vitro diagnostic solutions that utilize novel blood-based protein biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions, including acute heart failure, acute kidney injury, and circulatory shock. Sphingotec also produces microtiter plates, which are commonly used in analytical research and diagnostic testing laboratories. Its focus is on addressing critically underserved diagnostic needs in the field of acute care, with an emphasis on improving patient outcomes through innovative biomarker technologies.

Nyra Health is a digital therapy platform founded in 2020 and headquartered in Vienna, Austria. It focuses on addressing personal neurological deficits through an artificial intelligence-driven application. The platform provides evidence-based therapies that can be utilized in clinics or at home, making rehabilitation accessible regardless of time or location. By leveraging advanced technology, Nyra Health aims to empower patients to maximize their rehabilitation potential effectively.

Orcan Energy is the leader in waste heat recovery technology. Orcan Energy GmbH was founded in 2008, as a spin-out from the Technical University of Munich (“TUM”). Orcan’s ePack offers a compact, service-reduced and cost- efficient “plug-and-play” waste heat power generator based on ORC-Technology. Spe- cific patented innovations enable Orcan to popularize the technology on the mass mar- ket. At the beginning of 2013, Orcan gained sponsorships from the Exist-Research- Transfer-Aid of the Federal Government of Germany and additional grants from the “Wissensfabrik” and various resources from the TUM.

Aignostics GmbH, founded in 2018 and based in Berlin, Germany, specializes in AI-powered diagnostics and pathology software solutions aimed at enhancing pharmaceutical research and clinical diagnostics. The company focuses on precision diagnostics in pathology, employing its patented technology to create explainable AI systems that address the limitations of traditional AI models. By generating precise heatmaps and image overlays, Aignostics' platform enables pathologists to quickly verify AI-generated diagnostic results. This capability is essential for ensuring accuracy in diagnoses, particularly for complex diseases such as cancer. The company's innovative approach supports the discovery and validation of biomarkers, facilitating improved diagnosis and treatment strategies in precision medicine.

iOmx Therapeutics AG is a Munich-based company specializing in immuno-oncology target discovery and drug development. The firm focuses on creating innovative cancer therapeutics that target novel immune checkpoint modulators present on tumor cells. By employing a systematic screening approach of human tumor cells, iOmx Therapeutics has identified several new targets and examined their mechanisms of action. The company's foundation is built upon the principles of cancer immune-checkpoint therapy, which aims to overcome the resistance mechanisms that tumors utilize to evade immune attacks. These resistance mechanisms often involve specific cell surface molecules that activate immune-inhibitory receptors on T cells. By neutralizing these negative interactions, iOmx Therapeutics seeks to reactivate the host immune response, ultimately enhancing the effectiveness of cancer treatments.

Adrenomed AG is a clinical-stage biopharmaceutical company based in Hennigsdorf, Germany, focused on developing monoclonal antibody therapies for the treatment of sepsis and related conditions. The company's lead product candidate, Adrecizumab, is a humanized monoclonal antibody designed to target Adrenomedullin, a peptide hormone that plays a critical role in maintaining vascular integrity. Adrenomed aims to rescue vascular integrity in critically ill patients facing limited treatment options, particularly those suffering from septic shock and acute heart failure. The company employs a unique approach that combines its therapeutic antibody with a specific diagnostic tool that utilizes Adrenomedullin as a biomarker for patient identification. Adrenomed has established a strong intellectual property position, holding granted patents in all major markets for its innovative therapies.

Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.

AMBOSS GmbH is a digital platform based in Cologne, Germany, that caters to the needs of medical students and physicians. Founded in 2012, the company develops and markets a comprehensive medical study platform that offers valuable resources such as study materials and a question bank. The platform is designed to deliver medical knowledge quickly and efficiently, supporting users in their educational and professional endeavors. Originally established as MIAMED GmbH, AMBOSS has positioned itself as a physician-driven resource, enhancing the learning experience for those in the medical field.

Sphingotec GmbH is a biomarker company based in Brandenburg, Germany, founded in 2002. The company specializes in developing and marketing in vitro diagnostic solutions that utilize novel blood-based protein biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions, including acute heart failure, acute kidney injury, and circulatory shock. Sphingotec also produces microtiter plates, which are commonly used in analytical research and diagnostic testing laboratories. Its focus is on addressing critically underserved diagnostic needs in the field of acute care, with an emphasis on improving patient outcomes through innovative biomarker technologies.

Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.

As the technology leader in organic photovoltaics, Heliatek develops, produces and distributes industrial-grade organic PV solar solutions for virtually any building surface (horizontal, vertical, curved, rigid, and flexible). Heliatek stands for energy solutions designed for various traditional and never been possible before applications based on its unique features – it is ultra-light, flexible and truly green. HeliaSol® is a ready-to-use solution, ideal for retrofitting on existing building structures. HeliaFilm® is tailor-made solar film for companies in the building and construction material industry, to integrate into their façade or roof system products. Heliatek currently employs about 160 people at the Dresden and Ulm locations in Germany. The Free State of Saxony, the Federal Republic of Germany, and the European Union funded research and development, as well as the installation of the production technology.

As the technology leader in organic photovoltaics, Heliatek develops, produces and distributes industrial-grade organic PV solar solutions for virtually any building surface (horizontal, vertical, curved, rigid, and flexible). Heliatek stands for energy solutions designed for various traditional and never been possible before applications based on its unique features – it is ultra-light, flexible and truly green. HeliaSol® is a ready-to-use solution, ideal for retrofitting on existing building structures. HeliaFilm® is tailor-made solar film for companies in the building and construction material industry, to integrate into their façade or roof system products. Heliatek currently employs about 160 people at the Dresden and Ulm locations in Germany. The Free State of Saxony, the Federal Republic of Germany, and the European Union funded research and development, as well as the installation of the production technology.

iOmx Therapeutics AG is a Munich-based company specializing in immuno-oncology target discovery and drug development. The firm focuses on creating innovative cancer therapeutics that target novel immune checkpoint modulators present on tumor cells. By employing a systematic screening approach of human tumor cells, iOmx Therapeutics has identified several new targets and examined their mechanisms of action. The company's foundation is built upon the principles of cancer immune-checkpoint therapy, which aims to overcome the resistance mechanisms that tumors utilize to evade immune attacks. These resistance mechanisms often involve specific cell surface molecules that activate immune-inhibitory receptors on T cells. By neutralizing these negative interactions, iOmx Therapeutics seeks to reactivate the host immune response, ultimately enhancing the effectiveness of cancer treatments.

AMBOSS GmbH is a digital platform based in Cologne, Germany, that caters to the needs of medical students and physicians. Founded in 2012, the company develops and markets a comprehensive medical study platform that offers valuable resources such as study materials and a question bank. The platform is designed to deliver medical knowledge quickly and efficiently, supporting users in their educational and professional endeavors. Originally established as MIAMED GmbH, AMBOSS has positioned itself as a physician-driven resource, enhancing the learning experience for those in the medical field.

4SC is a clinical-stage biopharmaceutical company focused on discovering and developing targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases, particularly in areas with significant unmet medical needs. The company aims to offer innovative treatment options that enhance tolerability and efficacy, ultimately improving patients' quality of life. 4SC's drug development pipeline includes two clinical candidates, resminostat and Domatinostat, which are protected by a strong portfolio of patents. The company operates primarily in Germany and the European Union, while also generating revenue from various other countries.

ImevaX is a biopharmaceutical company founded in 2014 based in Munich, Germany. The focus is to combat chronic and nosocomial infections by creating specific vaccines. The company’s lead candidate IMX 101 is a vaccine against Helicobacter pylori, which colonizes the stomach and is the cause of ulcer disease and gastric cancer in humans. Founder Markus Gerhard and his team discovered that the colonization ability (and hence, the infectiousness) of H. pylori depends on a secreted bacterial factor that down-regulates the host immune system. Many other highly infectious pathogens have evolved similar immune evasion mechanisms, which are the focus of the ImevaX screening program.

As the technology leader in organic photovoltaics, Heliatek develops, produces and distributes industrial-grade organic PV solar solutions for virtually any building surface (horizontal, vertical, curved, rigid, and flexible). Heliatek stands for energy solutions designed for various traditional and never been possible before applications based on its unique features – it is ultra-light, flexible and truly green. HeliaSol® is a ready-to-use solution, ideal for retrofitting on existing building structures. HeliaFilm® is tailor-made solar film for companies in the building and construction material industry, to integrate into their façade or roof system products. Heliatek currently employs about 160 people at the Dresden and Ulm locations in Germany. The Free State of Saxony, the Federal Republic of Germany, and the European Union funded research and development, as well as the installation of the production technology.

Definiens is a company that specializes in image analysis and data mining solutions tailored for quantitative digital pathology within the life sciences, diagnostic biomarkers, and healthcare sectors. Its software offers detailed insights from whole tissue slides, cell-based assays, and full-body scans, enabling users to correlate this information with data from various sources. By automating analysis workflows, Definiens assists pharmaceutical and biotechnology firms, research institutions, clinical service organizations, and pathologists in generating new knowledge, thereby enhancing decision-making in research, diagnostics, and therapy. Headquartered in Munich, Germany, Definiens aims to advance research fields, contribute to the development of personalized medicine, and improve patient quality of life. The company also maintains offices across the United States.

Opvizor GmbH, founded in 2012 and based in Vienna, Austria, specializes in cloud-based expert systems designed to enhance the management of virtual IT infrastructures. Its flagship product, Opvizor, is an agent-less Software-as-a-Service application that offers automated detection of configuration and operational issues within VMware environments. By analyzing protocol files, configuration data, and performance metrics, Opvizor identifies potential system integrity and security vulnerabilities, allowing administrators to mitigate risks before they lead to costly downtime. The platform features a crowdsourced knowledge base, continuously updated with input from users, which enhances its predictive capabilities. Opvizor aims to optimize IT environments by providing comprehensive reports and efficient problem-solving guidance, ensuring greater stability and performance for data centers.

Dacuda is a computer vision company based in Zurich, Switzerland, with additional locations in Palo Alto, California, and Shanghai, China. The company specializes in developing software solutions that enhance camera capabilities through real-time 2D and 3D algorithms. Dacuda aims to simplify the process of 3D content creation for consumers, making it as straightforward as capturing a video. Its technology supports app-based scanning, facilitating the adoption of 3D applications in augmented and virtual reality. Additionally, Dacuda's offerings include low-cost solutions that enable high-quality scans, powerful text recognition, and the transformation of printed text and tables into editable formats. This technology streamlines data entry and content sharing for users. Dacuda has received several awards for its innovation and entrepreneurial achievements, highlighting its position as a leader in the software 3D camera market.

Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment. Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.

Readmill is a Berlin-based social reading platform that offers users the ability to read ebooks, highlight passages, and share these highlights with friends, fostering discussions around the content. Founded and led by CEO Henrik Berggren, Readmill has formed partnerships with several independent bookstores, including Leanpub, Readlists, Free-ebooks.net, Jottify, OR Books, Publit, and Bibliocrunch, enhancing its offerings and reach within the literary community. The platform aims to create a collaborative reading experience that combines individual engagement with social interaction.

bonusbox GmbH, founded in 2011 and based in Berlin, Germany, specializes in online loyalty programs and operates a multi-partner loyalty network. The company provides a customer retention platform that assists merchants in acquiring new customers and retaining existing ones through an incentive scheme. This approach aims to enhance customers' basket values and increase purchase frequencies. The platform is designed to integrate seamlessly into merchants' websites, allowing customers to earn points with each purchase. These points can be redeemed for rewards on the bonusbox platform, where users can also monitor their online purchases and accrued points while discovering additional partner shops. By structuring various customer data, bonusbox enables merchants to gain deeper insights into their customers' behaviors and preferences.

eWise is an international provider of personal financial management and account aggregation solutions, founded in 2000 and headquartered in Switzerland. The company offers a software platform that allows users to unify their financial accounts on a single screen, enhancing online payment, security, authentication, and wealth management. eWise Money Manager is utilized by several prominent banks, including HSBC, Westpac, and First Direct, demonstrating its credibility and innovative approach in the financial services sector. With operations spanning Europe, Asia, America, and Australia, eWise aims to facilitate a seamless and secure financial management experience for its users.

Sapiens Steering Brain Stimulation GmbH is an emerging medical device company whose mission is to deliver superior solutions for deep brain stimulation (DBS) therapy. Sapiens' ambition is to provide a unique, high-resolution, and MRI- compatible DBS system that will improve patient comfort and therapeutic outcome, initially for patients with Parkinson's disease. Sapiens, with offices in Eindhoven, the Netherlands and Munich, Germany, is founded in 2011 as a spin-out of Royal Philips Electronics. Its steering brain stimulation (SBS) system and image-guided programming are based upon patented technologies.

Enecsys Limited specializes in the development, manufacturing, and marketing of advanced solar micro inverters and monitoring systems designed for grid-connected solar photovoltaic (PV) applications. The company's micro inverters convert direct current (DC) power generated by individual solar modules into alternating current (AC) power for integration into the electricity grid. Key benefits of Enecsys micro inverters include maximized energy harvest, improved safety, enhanced reliability, and simplified design and installation processes. The accompanying monitoring system provides real-time performance tracking of each PV module, utilizing a robust wireless communication system that connects to the Internet. Enecsys is headquartered in Cambridge, UK, with additional sales and support offices in Germany, the USA, and Taiwan.

Orcan Energy is the leader in waste heat recovery technology. Orcan Energy GmbH was founded in 2008, as a spin-out from the Technical University of Munich (“TUM”). Orcan’s ePack offers a compact, service-reduced and cost- efficient “plug-and-play” waste heat power generator based on ORC-Technology. Spe- cific patented innovations enable Orcan to popularize the technology on the mass mar- ket. At the beginning of 2013, Orcan gained sponsorships from the Exist-Research- Transfer-Aid of the Federal Government of Germany and additional grants from the “Wissensfabrik” and various resources from the TUM.

Experteer is an online career and recruitment marketplace based in Munich, Germany, specializing in high-end job opportunities across Europe. It features over 80,000 job listings targeted at senior-level professionals and offers access to a confidential network of more than 8,000 recruiters and 10,000 selected headhunters. The platform is designed to assist experienced executives in navigating their career moves and monitoring their market value, providing tailored insights and resources. With a dedicated team of recruitment professionals, Experteer conducts market research to classify job opportunities and apply salary benchmarks, ensuring quality listings for its users. Additionally, it serves recruitment needs through job advertising and candidate sourcing for headhunters and agencies. Founded in 2005, Experteer has established itself as a trusted resource in the high-end recruitment sector.

Azzurro Semiconductors AG, a semiconductor company, specializes in gallium nitride (GaN)-on-silicon (Si) epi-wafers. The company also offers GaN-on-Si. Its products are used in high voltage electronics, FETs, LEDs, automotive, switching devices for power supplies, sensors, and other applications. The company is based in Madgeburg, Germany.

Experteer is an online career and recruitment marketplace based in Munich, Germany, specializing in high-end job opportunities across Europe. It features over 80,000 job listings targeted at senior-level professionals and offers access to a confidential network of more than 8,000 recruiters and 10,000 selected headhunters. The platform is designed to assist experienced executives in navigating their career moves and monitoring their market value, providing tailored insights and resources. With a dedicated team of recruitment professionals, Experteer conducts market research to classify job opportunities and apply salary benchmarks, ensuring quality listings for its users. Additionally, it serves recruitment needs through job advertising and candidate sourcing for headhunters and agencies. Founded in 2005, Experteer has established itself as a trusted resource in the high-end recruitment sector.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building and industrial automation. The company develops products that include energy converters, transmitters, receivers, and self-powered wireless sensors, which harvest energy from their environment for maintenance-free operation. These solutions are designed for various applications, including home automation, lighting, automated meter reading, and environmental monitoring. EnOcean's technology allows users to manage smart home systems and LED lighting efficiently and securely. The company distributes its products through a network of distributors in numerous countries, including the United States, Germany, and several others across Europe and Asia. EnOcean also has a subsidiary in the United States to support its operations in North America.

Evolva is a biotechnology company based in Reinach, Switzerland, founded in 2004. The company specializes in the research, development, and commercialization of nature-based ingredients that are ready for formulation. Utilizing a proprietary synthetic biology platform, Evolva creates innovative small-molecule compounds that replicate the beneficial properties of natural products while mitigating their disadvantages. Their offerings find applications in various sectors, including flavors and fragrances, health ingredients, and health protection. Through its advanced technology, Evolva aims to provide high-quality ingredients that meet the needs of diverse industries.

As the technology leader in organic photovoltaics, Heliatek develops, produces and distributes industrial-grade organic PV solar solutions for virtually any building surface (horizontal, vertical, curved, rigid, and flexible). Heliatek stands for energy solutions designed for various traditional and never been possible before applications based on its unique features – it is ultra-light, flexible and truly green. HeliaSol® is a ready-to-use solution, ideal for retrofitting on existing building structures. HeliaFilm® is tailor-made solar film for companies in the building and construction material industry, to integrate into their façade or roof system products. Heliatek currently employs about 160 people at the Dresden and Ulm locations in Germany. The Free State of Saxony, the Federal Republic of Germany, and the European Union funded research and development, as well as the installation of the production technology.

Symetis is a Swiss Company developing innovative minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases. Symetis is dedicated to improving patient care and safety by offering simple, accurate solutions for heart valve replacement. Its proprietary Acurateâ„¢Aortic Valve Replacement System features a unique self-positioning design providing facile implant positioning and alignment as well as unrivalled ease of use.

Enecsys Limited specializes in the development, manufacturing, and marketing of advanced solar micro inverters and monitoring systems designed for grid-connected solar photovoltaic (PV) applications. The company's micro inverters convert direct current (DC) power generated by individual solar modules into alternating current (AC) power for integration into the electricity grid. Key benefits of Enecsys micro inverters include maximized energy harvest, improved safety, enhanced reliability, and simplified design and installation processes. The accompanying monitoring system provides real-time performance tracking of each PV module, utilizing a robust wireless communication system that connects to the Internet. Enecsys is headquartered in Cambridge, UK, with additional sales and support offices in Germany, the USA, and Taiwan.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building and industrial automation. The company develops products that include energy converters, transmitters, receivers, and self-powered wireless sensors, which harvest energy from their environment for maintenance-free operation. These solutions are designed for various applications, including home automation, lighting, automated meter reading, and environmental monitoring. EnOcean's technology allows users to manage smart home systems and LED lighting efficiently and securely. The company distributes its products through a network of distributors in numerous countries, including the United States, Germany, and several others across Europe and Asia. EnOcean also has a subsidiary in the United States to support its operations in North America.

GameDuell is a cross-platform games community, developing games for its website as well as for social networks and mobile devices. With more than 125 million registered players across all platforms, the Berlin-based company counts among the casual and social games providers in the Western markets. GameDuell offers a broad portfolio of over 70 casual online games, mostly developed in-house, such as Fluffy, Maya Pyramid, Bubble Speed, Jungle Jewels, and game classics like Hearts, Solitaire, and Pool. It has a team of 210 experienced members. GameDuell was founded in 2003 by Kai Bolik, Michael Kalkowski, and Boris Wasmuth GameDuell. It is based in San Francisco, C.A.

Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment. Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.

Innovative Silicon was founded to develop and commercialise Floating Body effect memory for SoC/MPU products used in diverse applications including handheld computers, games consoles, cellular communications devices, cameras. The company closed its first round of VC funding in 2003, completed its first 90nm megabit Z-RAM memory design in 2004 and its first 65nm designs in 2005. The company was founded in 2002 and is headquartered in Santa Clara, California with additional offices in Lausanne, Switzerland; and Yokohama, Japan.

Experteer is an online career and recruitment marketplace based in Munich, Germany, specializing in high-end job opportunities across Europe. It features over 80,000 job listings targeted at senior-level professionals and offers access to a confidential network of more than 8,000 recruiters and 10,000 selected headhunters. The platform is designed to assist experienced executives in navigating their career moves and monitoring their market value, providing tailored insights and resources. With a dedicated team of recruitment professionals, Experteer conducts market research to classify job opportunities and apply salary benchmarks, ensuring quality listings for its users. Additionally, it serves recruitment needs through job advertising and candidate sourcing for headhunters and agencies. Founded in 2005, Experteer has established itself as a trusted resource in the high-end recruitment sector.

As the technology leader in organic photovoltaics, Heliatek develops, produces and distributes industrial-grade organic PV solar solutions for virtually any building surface (horizontal, vertical, curved, rigid, and flexible). Heliatek stands for energy solutions designed for various traditional and never been possible before applications based on its unique features – it is ultra-light, flexible and truly green. HeliaSol® is a ready-to-use solution, ideal for retrofitting on existing building structures. HeliaFilm® is tailor-made solar film for companies in the building and construction material industry, to integrate into their façade or roof system products. Heliatek currently employs about 160 people at the Dresden and Ulm locations in Germany. The Free State of Saxony, the Federal Republic of Germany, and the European Union funded research and development, as well as the installation of the production technology.

Ingent Inc., a Germany-based provider of information retrieval infrastructure technologies for computer applications.

XING Is the social network for business professionals. More than 13 million members worldwide – over 6.5 million of whom are based in german-speaking countries – use xing to boost their business, job, and career. Xing is a platform where professionals from all kinds of different industries can meet up, find jobs, colleagues, new assignments, cooperation partners, experts and generate business ideas. Members can meet and exchange views in over 50,000 specialist groups, while also getting together at networking events. The platform is operated by xing ag, which was founded in hamburg, germany, in 2003, has been publicly listed since 2006, and listed on the tecdax since september 2011. In december 2010, xing acquired amiando ag, a munich-based company and europe’s leading provider of online event management and ticketing. The acquisition of kununu gmbh, the leading platform for employer reviews in german-speaking countries, allows xing to extend its position as the social recruiting market leader.

VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

Collax GmbH specializes in developing Linux-based server solutions tailored for small to medium-sized businesses. Founded in 2005 and headquartered in Ismaning, Germany, with additional offices in Munich and Boston, the company provides a range of products. Its offerings include the Collax Business Server, which facilitates network creation and maintenance, and the Collax OX Server, designed for efficient information exchange. The Collax Security Gateway serves as a unified threat management solution, enhancing network security. Additionally, Collax provides various integrated services, including data management, email, collaboration tools, and security features such as firewalls and virus protection. By focusing on adaptability, stability, and security, Collax aims to support its clients in improving productivity while ensuring robust IT infrastructure.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building and industrial automation. The company develops products that include energy converters, transmitters, receivers, and self-powered wireless sensors, which harvest energy from their environment for maintenance-free operation. These solutions are designed for various applications, including home automation, lighting, automated meter reading, and environmental monitoring. EnOcean's technology allows users to manage smart home systems and LED lighting efficiently and securely. The company distributes its products through a network of distributors in numerous countries, including the United States, Germany, and several others across Europe and Asia. EnOcean also has a subsidiary in the United States to support its operations in North America.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building and industrial automation. The company develops products that include energy converters, transmitters, receivers, and self-powered wireless sensors, which harvest energy from their environment for maintenance-free operation. These solutions are designed for various applications, including home automation, lighting, automated meter reading, and environmental monitoring. EnOcean's technology allows users to manage smart home systems and LED lighting efficiently and securely. The company distributes its products through a network of distributors in numerous countries, including the United States, Germany, and several others across Europe and Asia. EnOcean also has a subsidiary in the United States to support its operations in North America.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building and industrial automation. The company develops products that include energy converters, transmitters, receivers, and self-powered wireless sensors, which harvest energy from their environment for maintenance-free operation. These solutions are designed for various applications, including home automation, lighting, automated meter reading, and environmental monitoring. EnOcean's technology allows users to manage smart home systems and LED lighting efficiently and securely. The company distributes its products through a network of distributors in numerous countries, including the United States, Germany, and several others across Europe and Asia. EnOcean also has a subsidiary in the United States to support its operations in North America.